Recent insights into the pathophysiology of atrial fibrillation.
Although the problem of atrial fibrillation is now widely appreciated, the fundamental mechanisms that lead to arrhythmia onset and persistence have been difficult to elucidate. As a result, available pharmacologic therapies have focused more on modifying ion channel activity than on the underlying mechanisms. Recent studies suggest an important role for alterations in autonomic regulation, neurohormonal activation, and a systemic inflammatory state in the genesis and persistence of atrial fibrillation. The relative contributions of these distinct pathways to atrial fibrillation likely vary from patient to patient, and within a patient, as a function of age. Tailored therapies, together with patient-specific ablative interventions, may increase the success with which atrial fibrillation is treated and minimize the occurrence of life-threatening thromboembolic complications.
Van Wagoner
David R
DR
Department of Molecular Cardiology, Cleveland Clinic, Cleveland, Ohio 44195, USA. VANWAGD@ccf.org
D001281:Atrial Fibrillation / Q000209:etiology / Q000503:physiopathology* / Q000601:surgery; D018880:Atrial Premature Complexes; D018450:Disease Progression; D006801:Humans; D011183:Postoperative Complications; D011667:Pulmonary Veins / Q000473:pathology* / Q000601:surgery; D012307:Risk Factors